Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Curcumin on the Reduction of Cellular Inflammation Markers in Hemodialysis Patients

NCT06829186 is registered in ClinicalTrials.gov with University of Guadalajara as lead sponsor.

NCT NCT06829186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06829186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Curcumin on the Reduction of Cellular Inflammation Markers in Hemodialysis Patients
Lead sponsor
University of Guadalajara
Phase
Phase 2
Overall status
Not yet recruiting
Start date
March 15, 2025
Completion date
December 30, 2026
Enrollment
70 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis